Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicityBo Meng, Jenny Kourampa, Daichi Yamasoba et al.|Nature|2022Cited by 1.2k
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2Dami A. Collier, Josh Hodgson, Isabella A.T.M. Ferreira et al.|Nature|2021Cited by 816
SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicityBo Meng, Federica Mescia, Rawlings Datir et al.|Cell Reports|2022Cited by 55